Spine Journal - 2026-04-13 - Journal Article; Review
The Impact of Preoperative Central Sensitization and Novel Mitigation Strategies on Outcomes Following Spinal Surgery: A Comprehensive Narrative Review.
Karami M, Kahn HA, Fakhrzadegan M, Abdul-Jabbar A, Oskouian R, Chapman J
Topics
Key Takeaway
Preoperative CSI scores ≥40 and abnormal QST findings consistently predict worse postoperative pain, disability, and quality of life after spinal surgery, with CS prevalence of 10–20% in elective spine surgical populations.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This narrative review synthesized evidence on preoperative central sensitization (CS) as an outcome predictor in elective spinal surgery, searching five databases through September 2025 and identifying 11 qualifying studies spanning lumbar disc herniation to cervical myelopathy. Higher preoperative CSI scores (≥40) and abnormal QST parameters (reduced pressure pain thresholds, impaired conditioned pain modulation, increased temporal summation) were consistently associated with greater postoperative pain, disability, depression, and longer hospital stays. Leg pain relief after decompression appeared relatively preserved despite elevated CS status in some cohorts, and perioperative pain neuroscience education (PPNE) demonstrated measurable CSI score improvement, particularly in high-kinesiophobia subgroups.
Key Limitation
The review includes only 11 studies with unreported aggregate sample sizes and heterogeneous outcome measures, preventing any quantitative synthesis or determination of effect magnitude for CS on surgical outcomes.
Original Abstract
Central sensitization (CS) is heightened central nervous system responsiveness to nociceptive input and contributes to the transition from acute to chronic pain. Although increasingly recognized as a predictor of suboptimal outcomes after spinal surgery, no prior review has been synthesized the associations between preoperative CS, underlying mechanisms, and potential perioperative mitigation strategies in spine surgery. This narrative review searched PubMed, Embase, Ovid, the Cochrane Library, and Google Scholar through September 2025 for studies examining preoperative CS-primarily diagnosed using the Central Sensitization Inventory (CSI), Quantitative Sensory Testing (QST), or related tools-in adults undergoing elective spinal surgery. Eleven studies met inclusion criteria, spanning from lumbar disk herniation to cervical myelopathy. Higher preoperative CSI scores (especially ≥40) and abnormal QST findings (reduced pressure pain thresholds, increased temporal summation, impaired conditioned pain modulation) were consistently associated with worse postoperative outcomes, including greater pain intensity, increased disability, poorer quality of life, elevated depressive symptoms, and longer hospital stays. However, leg pain relief after decompression appeared less influenced by CS status in some cohorts. CS prevalence ranged from 10-20% in preoperative populations, with risk factors including prolonged symptom duration, visceral adiposity, pain catastrophizing, and revision surgery. Persistent nociceptive input from degenerative pathology promotes neuroplastic amplification and impaired descending inhibition. Emerging evidence suggests CS may be modifiable: perioperative pain neuroscience education (PPNE) improves CS scores-particularly in high kinesiophobia subgroups-and animal models indicate that intraoperative neuromodulation may decrease postoperative CS development. Preoperative CS screening (e.g., CSI ≥40) should be included into surgical risk assessment . Targeted prehabilitation (PPNE plus exercise), weight optimization, multimodal analgesia, and exploration of intraoperative neuromodulation are promising strategies to mitigate CS related adverse outcomes.